Sign in Subscribe
Clinical trials

Managing Fatigue in Parkinson's Disease: New Pilot Study Findings

Strategic Insights

— 2 min read

A new pilot study evaluating the individual videoconference version of a program for people with Parkinson's disease (PD) has been published in the Journal of Parkinson's Disease. The study aimed to assess the feasibility and preliminary effectiveness of the program in reducing fatigue and improving quality of life for individuals with PD. The research, conducted by a team from Dalhousie University, involved a two-arm, randomized controlled pilot study recruiting 25 participants with severe fatigue. The results showed exploratory trends toward significant improvements in satisfaction with performance, occupational balance, and occupational performance, with moderate to small effect sizes observed.

Key Takeaways:

  • The study aimed to evaluate the feasibility and preliminary effectiveness of the individual videoconference version of a program to reduce fatigue in people with Parkinson's disease.
  • The research involved a two-arm, randomized controlled pilot study with 25 participants who experienced severe fatigue.
  • The results showed an exploratory trend toward significant improvements in satisfaction with performance, occupational balance, and occupational performance.
  • Moderate to small effect sizes were observed for these outcomes, indicating a potential benefit of the program.
  • The study concluded that larger, more rigorous studies are needed to confirm the effectiveness of the program.
  • The research team praised the findings, stating that despite the small sample size and challenges posed by COVID-19, the study offers valuable insights into recruitment strategies and effect sizes for future trial designs.
  • The program's individual videoconference format may provide an accessible and effective way to manage fatigue in people with PD.

Statistics:

  • 25 participants were recruited for the two-arm, randomized controlled pilot study.
  • The study showed an exploratory trend toward significant improvements in satisfaction with performance, occupational balance, and occupational performance.
  • Moderate to small effect sizes were observed for these outcomes, with an effect size of 0.04 for satisfaction with performance and small to moderate effect sizes (0.09-0.26) for occupational balance, occupational performance, and subscales of the Multidimensional Fatigue Inventory.
  • 0.09-0.26 effect sizes indicate a moderate to small effect size, suggesting a potential benefit of the program.
  • 15% (3 out of 25 participants) showed significant improvement in satisfaction with performance.
  • The study was conducted during the COVID-19 pandemic, which posed challenges to recruitment and data collection.

Sources:

  • NewsRx (October 27, 2025): Studies from Dalhousie University Yield New Data on Parkinson's Disease (Managing fatigue in Parkinson's disease: Preparing for a randomized controlled trial).
  • Journal of Parkinson's Disease, (2025): "Managing fatigue in Parkinson's disease: Preparing for a randomized controlled trial".
  • Tanya Packer, School of Occupational Therapy, Faculty of Health, Dalhousie University, Halifax, Canada.
  • Ios Press, Nieuwe Hemweg 6B, 1013 Bg Amsterdam, Netherlands (publisher of the Journal of Parkinson's Disease).

Read more